Abstract
Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Current Cancer Therapy Reviews
Title:Lung Cancer Brachytherapy
Volume: 14 Issue: 2
Author(s): Edward Yu*Craig Lewis
Affiliation:
- Department of Oncology, Western University, Ontario, ON N6A-4L6,Canada
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Abstract: Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Export Options
About this article
Cite this article as:
Yu Edward *, Lewis Craig , Lung Cancer Brachytherapy, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573394714666180208145420
DOI https://dx.doi.org/10.2174/1573394714666180208145420 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PI-3-Kinase Inhibitors in Colorectal Cancer
Current Cancer Drug Targets The Pathogenesis of Lung Cancer and Chromosome 11
Current Genomics microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design Structure and Ligand-based Design of P-glycoprotein Inhibitors: A Historical Perspective
Current Pharmaceutical Design A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, <i>In silico</i> and <i>In vitro</i> Studies Providing Mechanistic Insight into Their Anticancer Potencies
Medicinal Chemistry Editorial [Hot Topic: Molecular Tools in Cancer Diagnosis and Therapy Guest Editor: Riyaz Basha]
Current Medicinal Chemistry Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets Pharmacogenetics of Estrogen Metabolism and Transport in Relation to Cancer
Current Drug Metabolism Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils
Current Pharmaceutical Design Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals Treatment of Metastases to the Vertebrae with Radiofrequency Ablation: Determination of Effectiveness by Evaluation of Tumor Necrosis – A Preliminary Result
Current Radiopharmaceuticals Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo
Letters in Drug Design & Discovery Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets Integrated Genomic and Pharmacological Approaches to Identify Synthetic Lethal Genes as Cancer Therapeutic Targets
Current Molecular Medicine Alpha-Particle Microdosimetry
Current Radiopharmaceuticals Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets Design, Synthesis and Anticancer Evaluation of Acetamides Comprising 1,2,3-triazole, 1,3,4-thiadiazole and Isothiazolo[4,3-b]pyridine Rings
Letters in Organic Chemistry Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases
Current Cancer Drug Targets